Regeneron Pharmaceuticals (60) | License Agreements (3)

Recent Contracts

License Agreement, dated as of August 18, 2020, by and among the Registrant, F. Hoffman-La Roche Ltd, and Genentech, Inc (Filed With SEC on November 5, 2020)
Praluent Cross License & Commercialization Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant and Sanofi Biotechnology SAS (Filed With SEC on August 5, 2020)
Form of License Agreement (Exhibit C to Master Agreement contained in Exhibit 10.4) (Filed With SEC on August 6, 2019)